Cholelithiasis in mice: effects of different chemicals upon formation and prevention of gallstones.
D000438:Alcohols / Q000627:therapeutic use*; D000818:Animals; D001205:Ascorbic Acid / Q000627:therapeutic use*; D002769:Cholelithiasis / Q000139:chemically induced* / Q000209:etiology / Q000517:prevention & control; D002784:Cholesterol / Q000097:blood / Q000378:metabolism; D002791:Cholesterol, Dietary; D002793:Cholic Acids; D005234:Fatty Liver / Q000150:complications; D005260:Female; D006146:Guanidines / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D009355:Neomycin / Q000627:therapeutic use*; D010368:Pectins / Q000627:therapeutic use*; D010713:Phosphatidylcholines / Q000097:blood / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*
D000438:Alcohols; D002791:Cholesterol, Dietary; D002793:Cholic Acids; D006146:Guanidines; D010713:Phosphatidylcholines; D013449:Sulfonamides; D010368:Pectins; D002784:Cholesterol; D009355:Neomycin; D001205:Ascorbic Acid